Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 2
2004 1
2005 2
2006 1
2007 1
2008 5
2009 2
2010 3
2011 5
2012 13
2013 29
2014 24
2015 23
2016 30
2017 18
2018 24
2019 29
2020 18
2021 20
2022 14
2023 17
2024 26
2025 26
2026 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

305 results

Results by year

Filters applied: . Clear all
Page 1
Pentito.
Abel GA. Abel GA. JAMA Oncol. 2019 Apr 1;5(4):580. doi: 10.1001/jamaoncol.2018.6869. JAMA Oncol. 2019. PMID: 30763415 No abstract available.
Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction: A Randomized Clinical Trial.
Wong JS, Uno H, Tramontano AC, Fisher L, Pellegrini CV, Abel GA, Burstein HJ, Chun YS, King TA, Schrag D, Winer E, Bellon JR, Cheney MD, Hardenbergh P, Ho A, Horst KC, Kim JN, Leonard KL, Moran MS, Park CC, Recht A, Soto DE, Shiloh RY, Stinson SF, Snyder KM, Taghian AG, Warren LE, Wright JL, Punglia RS. Wong JS, et al. Among authors: abel ga. JAMA Oncol. 2024 Oct 1;10(10):1370-1378. doi: 10.1001/jamaoncol.2024.2652. JAMA Oncol. 2024. PMID: 39115975 Free PMC article. Clinical Trial.
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.
Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN. Zhou Z, et al. Among authors: abel ga. Blood. 2014 Feb 6;123(6):837-42. doi: 10.1182/blood-2013-09-524108. Epub 2013 Nov 21. Blood. 2014. PMID: 24264230 Free PMC article.
Challenges of diagnosing rare cancers in primary care.
Moore SF, Abel GA, Mounce LT. Moore SF, et al. Among authors: abel ga. Br J Gen Pract. 2024 Jul 25;74(745):340-341. doi: 10.3399/bjgp24X738789. Print 2024 Aug. Br J Gen Pract. 2024. PMID: 39054086 Free PMC article. No abstract available.
The Art of the Art of Oncology.
Sekeres MA, Abel GA, Gilligan T, Graff SL, Kalemkerian GP, Korones DN, Loren AW, McNeil C, Riches JC. Sekeres MA, et al. Among authors: abel ga. J Clin Oncol. 2025 Aug 20;43(24):2664-2666. doi: 10.1200/JCO-25-01205. Epub 2025 Jul 14. J Clin Oncol. 2025. PMID: 40658914 No abstract available.
Patient-reported outcomes: a Polaris for POLARIX.
Odejide OO, Abel GA. Odejide OO, et al. Among authors: abel ga. Blood. 2026 Jan 15;147(3):219-220. doi: 10.1182/blood.2025031427. Blood. 2026. PMID: 41538210 No abstract available.
Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML.
Garcia JS, Kim HT, Murdock HM, Bosch-Vilaseca A, Panaro KM, Lim F, Fiorilla J, Auriemma E, Brock J, Gooptu M, Ho VT, Cutler CS, Shapiro R, Kelkar AH, Abel GA, DeAngelo DJ, Stone RM, Bat-Erdene D, Ryan J, Fell G, Letai A, Ritz J, Lindsley RC, Antin JH, Soiffer RJ. Garcia JS, et al. Among authors: abel ga. Blood Adv. 2026 Mar 10;10(5):1548-1558. doi: 10.1182/bloodadvances.2025018631. Blood Adv. 2026. PMID: 41348911 Free PMC article. Clinical Trial.
305 results